NCT03712683View on ClinicalTrials.gov

Thyroxin in Subclinical Hypothyroidism

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Sub Clinical HypothyroidismPregnancy Loss
Interventions
DRUG

Thyroxine

Thyroxine was prescribed with the diagnosis of SCH and continued when pregnancy was confirmed

All Listed Sponsors
lead

Hawler Medical University

OTHER

NCT03712683 - Thyroxin in Subclinical Hypothyroidism | Biotech Hunter | Biotech Hunter